Scheffer C. G. Tseng

TissueTech, Inc. develops and manufactures regenerative amniotic tissue-based products. Its products include aminiograft, prokera, cliradex, and neox. It serves ophthalmology, optometry, musculoskeletal, and wound care markets. The company was founded by Amy H. Tseng and Scheffer Tseng in 1997 and is headquartered in Miami, FL.

Part of TissueTech, Inc., Bio-tissue, Inc. is a biotechnology company that specializes in using human birth tissue to support regenerative healing for ocular surface disease and in surgical, chronic wound, and musculoskeletal applications. The company is based in Miami, FL. The company's portfolio of cryopreserved amniotic membrane products uses its proprietary cryotek® cryopreservation technology, designed to retain the tissues' structural and functional integrity. Bio-tissue is committed to empowering healthcare professionals with solutions to deliver optimal patient outcomes by fostering innovation through evidence-based science. The company was founded in 1997 by Amy H. Tseng, Scheffer C. G. Tseng. Timothy E. Davis has been the CEO of the company since 2022.